vimarsana.com

Latest Breaking News On - தேசிய பால் வளர்ச்சி - Page 1 : vimarsana.com

Hyderabad-based IIL to produce drug substance for Covaxin

Coronavirus LIVE updates: Maharashtra logs 20,740 fresh Covid-19 cases, 424 fatalities in last 24 hours

Coronavirus LIVE updates May 28: India recorded 1.86 lakh new Covid-19 cases in the last 24 hours, the lowest daily spike in nearly 40 days. The country's active caseload has further declined to 23,43,152, while the recovery rate increased to 90.34 per cent, as per the Union health ministry's data released on Friday morning. Amid this, the government said the second Covid-19 wave in India is on the "downswing", but also highlighted that the.

Hyderabad Based Indian Immunological limited To Supply Drug Substance Required To Make Bharat Biotech s Covaxin

Hyderabad Based Indian Immunological limited To Supply Drug Substance Required To Make Bharat Biotech s Covaxin
swarajyamag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swarajyamag.com Daily Mail and Mail on Sunday newspapers.

Indian Immunological Ltd to produce Covaxin materials from mid-June

Indian Immunological Ltd to produce Covaxin materials from mid-June ​ By IANS | ​ 0 Views   Kolkata: Health workers give the 1st dose of vaccine to the Government workers during increasing numbers of COVID 19 cases in Kolkata 24 May, 2021. (Photo: Kuntal Chakrabarty/ IANS). Image Source: IANS News New Delhi, May 29 : In a bid to augment India s Covid-19 vaccine production, the Centre has decided to support some public sector companies with grants under Mission Covid Suraksha to help in this endeavour. One such company is the Hyderabad-based Indian Immunological Ltd (IIL), under the National Dairy Development Board. A technical collaboration agreement has been reached between IIL and Bharat Biotech to supply the drug substance required for manufacturing of Covaxin to the latter, an official statement said.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.